Kicking off the 6th #3TR Meeting in Barcelona! 150+ experts from 69 partners are advancing #crossdisease research and improving care for autoimmune, inflammatory & allergic diseases. Exciting days ahead of collaboration and insight! ✨ #3TR #IMI #HorizonEurope

🌍#WorldIBDDay2025 #IKMB and the Cluster of Excellence “Precision Medicine in Chronic Inflammation”, which conducts research into #IBD lit their two buildings in purple on the campus of #UniKiel to raise awareness and support patients worldwide.💜See more: https://t.co/MDBh5r1LiW

Terrific effort of the whole investigator team in Hamburg, Hannover&Kiel as well as the translational labs involved. @UKSH_KI_HL @kieluni @medinflame @3TR_IMI @DDWMeeting @Y_ECCO_IBD @my_ueg @KonradAden @MWiestler @IBD_FloMD @Bealoquebea @DCCV_Germany

We did see a superiority of the molecular medicine care arm, means those with continuous biomarker measurement and reporting to the treating IBD doctor. This substantially improved the outcomes of our patients.

Proud to have presented results of our GUIDE IBD study today in THE clinical science late-breaker session of DDW with vivid discussions. For the first time in the IBD field, we used molecular biomarkers throughout a clinical study to guide individual therapy decisions.

Team Kiel @DDWMeeting ! @UKSH_KI_HL @kieluni representation of multiple projects @3TR_IMI @medinflame @Y_ECCO_IBD @my_ueg Concluding the last day with two more oral presentations from Kiel, don't miss!

@Y_ECCO_IBD @my_ueg @UZLeuven @Bealoquebea @mgroussi @ImmUniverse_EU @IBD_FloMD @burisch @JKupcinskasLT @BettenworthDb

Dear IBD community, I am currently hiring for a position of a PhD candidate. If you are interested in a hybrid experimental/computational work with a specific focus on immune interaction in IBD tissue please apply! For details see here: https://t.co/cTAv7cta9G

@medicine_e @SystemsImmunol1 @BioInfoGen1 @3TR_IMI @ImmUniverse_EU @UKSH_KI_HL @kieluni @DGVSJuGa @my_ueg

It's a great honour to be elected as a new Y-ECCO board member. Thanks to the ECCO family and Y-ECCO team for the warm welcome! Looking forward to the activities in the next 3 years with this excellent group to represent the young IBD community in Europe.

🚨 Kicking off #ECCO2025 with a great ClinCom session led by @J_Kirchgesner Fantastic talks and amazing people 🙏🏽

All you need to know about Typical Atrial Flutter as #YoungestDGK and @YoungDgk ! #EP_Kiel @evgeny_lyan @sebFeickert @laura_rottner @ChristianHeeger @DavidDuncker @Hannah_Billig_ @Kardiophil @BerkanKurtMD @HenrikeHillmann @narrowQRS @HubrichtD @melhamriti @LuisEichelmann

Characterisation of #IBD #heterogeneity using serum #proteomics, a first study by the @CollibriIbd consortium. A multicentre study by Salomon and Sudhakar et al. @jonashalfvarson @SeverineVermei1 @bverstockt https://t.co/xYugUrMlgo

Defining what matters most to our patient and setting goals for 2025. Great and productive meeting, thanks for letting me represent the IBD disease area! @3TR_IMI @UKSH_KI_HL @Y_ECCO_IBD @bverstockt @efcca @DCCV_Germany @jonashalfvarson @kieluni

Day 1 of the #3TR Annual Meeting is done! ✅ What a fantastic start with insightful presentations, progress updates and breakout sessions! 🙌 We’d also like to thank our host @AstraZeneca for making this meeting possible! See you tomorrow for Day 2! #3TR #Gothenburg

#Gut #microbial species and #endotypes associate with remission in #UC patients treated with #antiTNF or #antiintegrin therapy Tamburini et al. https://t.co/zI4yAN2DlE

Dysregulation of adipose-stem cells in Crohn’s disease @IBODI_Group Montfort-Ferré et al. https://t.co/byk84lFuMq